443 related articles for article (PubMed ID: 27891127)
1. Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.
Metzemaekers M; Van Damme J; Mortier A; Proost P
Front Immunol; 2016; 7():483. PubMed ID: 27891127
[TBL] [Abstract][Full Text] [Related]
2. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.
Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769
[TBL] [Abstract][Full Text] [Related]
3. The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer.
De Zutter A; Van Damme J; Struyf S
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503058
[TBL] [Abstract][Full Text] [Related]
4. Chemokine isoforms and processing in inflammation and immunity.
Proost P; Struyf S; Van Damme J; Fiten P; Ugarte-Berzal E; Opdenakker G
J Autoimmun; 2017 Dec; 85():45-57. PubMed ID: 28684129
[TBL] [Abstract][Full Text] [Related]
5. CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.
Mortier A; Gouwy M; Van Damme J; Proost P; Struyf S
J Leukoc Biol; 2016 Jun; 99(6):955-69. PubMed ID: 26744452
[TBL] [Abstract][Full Text] [Related]
6. Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.
Proost P; Struyf S; Schols D; Opdenakker G; Sozzani S; Allavena P; Mantovani A; Augustyns K; Bal G; Haemers A; Lambeir AM; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 1999 Feb; 274(7):3988-93. PubMed ID: 9933589
[TBL] [Abstract][Full Text] [Related]
7. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
[TBL] [Abstract][Full Text] [Related]
8. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
[TBL] [Abstract][Full Text] [Related]
9. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines.
Sozzani S; Allavena P; Vecchi A; Van Damme J; Mantovani A
Pharm Acta Helv; 2000 Mar; 74(2-3):305-12. PubMed ID: 10812974
[TBL] [Abstract][Full Text] [Related]
11. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
Van Coillie E; Proost P; Van Aelst I; Struyf S; Polfliet M; De Meester I; Harvey DJ; Van Damme J; Opdenakker G
Biochemistry; 1998 Sep; 37(36):12672-80. PubMed ID: 9730840
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine.
Ludwig A; Schiemann F; Mentlein R; Lindner B; Brandt E
J Leukoc Biol; 2002 Jul; 72(1):183-91. PubMed ID: 12101279
[TBL] [Abstract][Full Text] [Related]
13. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
[TBL] [Abstract][Full Text] [Related]
14. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.
Mortier A; Gouwy M; Van Damme J; Proost P
Exp Cell Res; 2011 Mar; 317(5):642-54. PubMed ID: 21146523
[TBL] [Abstract][Full Text] [Related]
15. Regulation of chemokine activity by posttranslational modification.
Mortier A; Van Damme J; Proost P
Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic processing of chemokines: implications in physiological and pathological conditions.
Wolf M; Albrecht S; Märki C
Int J Biochem Cell Biol; 2008; 40(6-7):1185-98. PubMed ID: 18243768
[TBL] [Abstract][Full Text] [Related]
17. The role of CD26/dipeptidyl peptidase IV in cancer.
Havre PA; Abe M; Urasaki Y; Ohnuma K; Morimoto C; Dang NH
Front Biosci; 2008 Jan; 13():1634-45. PubMed ID: 17981655
[TBL] [Abstract][Full Text] [Related]
18. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
[TBL] [Abstract][Full Text] [Related]
19. Good or evil: CD26 and HIV infection.
Ohtsuki T; Tsuda H; Morimoto C
J Dermatol Sci; 2000 Apr; 22(3):152-60. PubMed ID: 10698152
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26.
Broxmeyer HE; Capitano M; Campbell TB; Hangoc G; Cooper S
Stem Cells Dev; 2016 Apr; 25(8):575-85. PubMed ID: 26943017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
